Related Experiment Video
Updated: Jan 25, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
Targeting CLL-1 for acute myeloid leukemia therapy
Hongbing Ma1, Iyer Swaminathan Padmanabhan2, Simrit Parmar3
1Hematology Department, West China Hospital, Sichuan University, Chengdu, China.
Despite advances, acute myeloid leukemia (AML) treatment remains challenging. Research highlights CLL-1 as a promising target for novel immunotherapies due to its specific expression on AML cells.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Acute myeloid leukemia (AML) treatment outcomes, particularly for adults, remain poor despite decades of research.
- Emerging immunotherapies for AML target specific cell surface markers like CD33, CD123, and CLL-1.
Purpose of the Study:
- To review the expression of CLL-1 in normal cells versus AML.
- To evaluate the diagnostic and follow-up value of CLL-1.
- To provide an overview of CLL-1-targeting immunotherapies, including antibody and chimeric antigen receptor T cell therapy.
Main Methods:
- Literature review of studies on CLL-1 expression and targeting in AML.
- Analysis of data regarding CLL-1's role in AML diagnosis and patient monitoring.
- Examination of therapeutic strategies utilizing CLL-1 as a target.
Main Results:
- CLL-1 is highly expressed on AML cells but absent in normal hematopoietic stem cells, making it an attractive therapeutic target.
- Evidence supports CLL-1's utility in AML diagnosis and disease follow-up.
- Antibody-based and CAR T-cell therapies targeting CLL-1 show potential for AML treatment.
Conclusions:
- CLL-1 represents a highly specific and valuable target for the immunotherapy of acute myeloid leukemia.
- Targeting CLL-1 offers a promising avenue for improving treatment outcomes in AML patients.
More Related Videos
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Differentiation of Common Myeloid Progenitor Cells
Psychodynamic Therapy
Humanistic Therapy